| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |